The FDA’s accelerated approval process: When drugs are cleared for sale based on limited evidence
…and Medicaid pay millions—maybe billions—of dollars for drugs for which we do not know the real benefits and risks. This raises insurance premiums and wastes tax dollars,” write Sarah DiMagno,…
Expert Commentary